Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2010
05/25/2010US7723523 Tetrahydropyridothiophenes
05/25/2010US7723521 Azaperylenes as organic semiconductors
05/25/2010US7723518 reacting 2-amino-3-hydroxypyridine with slight molar excess of 2-acetylbutyrolactone while azeotropically removing water, in solvent such as 4-methyl-2-pentanol, in presence of catalytic amount of acid at reflux; working up via adding alcohol and heating to reflux; crystallizing
05/25/2010US7723374 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
05/25/2010US7723355 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
05/25/2010US7723352 Isoquinolinone potassium channel inhibitors
05/25/2010US7723350 (1S)-2-(6-chloro-1,2-dihydro-1'H-spiro[indole-3,4'-piperidin]-1'-yl)-1-{1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinyl}ethanol; gene overexpression
05/25/2010US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions
05/25/2010US7723347 Substituted phenylamino-pyrimidines
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/25/2010US7723323 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions
05/25/2010US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/20/2010WO2010057126A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010WO2010057121A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
05/20/2010WO2010057104A2 Pyridoindole modulators of nmda receptor and acetylcholinesterase
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010057006A1 Azaquinolinone derivatives and uses thereof
05/20/2010WO2010056999A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
05/20/2010WO2010056992A1 Methods of preventing and treating low bone mass diseases
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056849A1 Gamma secretase modulators
05/20/2010WO2010056633A2 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/20/2010WO2010056230A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
05/20/2010WO2010056195A1 New compounds 575
05/20/2010WO2010056194A1 5h-pyrrolo [ 3, 4-b] pyridin derivatives and their use
05/20/2010WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010WO2010055083A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010WO2010054763A1 Heterocyclically substituted aryl compounds as hif inhibitors
05/20/2010US20100125138 PROCESS FOR MAKING (R)-3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
05/20/2010US20100125137 Process for preparing Nevirapine
05/20/2010US20100125089 Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
05/20/2010US20100125087 New compounds 575
05/20/2010US20100125085 Pyridoindole modulators of nmda receptor and acetylcholinesterase
05/20/2010US20100125081 New compounds 574
05/20/2010US20100125065 Carboline derivatives useful in the inhibition of angiogenesis
05/20/2010US20100125062 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010US20100123388 Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device
05/20/2010CA2743717A1 Azaquinolinone derivatives and uses thereof
05/20/2010CA2743715A1 Enantiomerically enriched aryloazol-2-yl cyanoethylamino paraciticidal compounds
05/20/2010CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/20/2010CA2743073A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010CA2742993A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
05/20/2010CA2742922A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010CA2742833A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010CA2742486A1 Gamma secretase modulators
05/20/2010CA2740389A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
05/19/2010EP2186901A2 Mutations in the BCR-Abl-tyrosine kinase associated with resistance to STI-571
05/19/2010EP2186813A1 Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
05/19/2010EP2186516A1 Novel benzazepine derivative
05/19/2010EP2185558A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
05/19/2010EP2185557A2 Perharidines as cdk inhibitors
05/19/2010EP2185556A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
05/19/2010EP2185555A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
05/19/2010EP2185554A1 Silicon derivatives as histone deacetylase inhibitors
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010EP2184990A2 3' substituted compounds having 5-ht6 receptor affinity
05/19/2010EP1899335B1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors
05/19/2010EP1720871B1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/19/2010CN101711249A Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer
05/19/2010CN101711243A 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
05/19/2010CN101709061A Quinolizidine alkaloid and application thereof in anti-tumor aspect
05/19/2010CN101245065B Method for producing benzo isoxazole derivative and its intermediate
05/19/2010CN101102769B Synthesis of sodium narcistatin and related compounds
05/18/2010US7718803 dispersion and storage stability; light resistance
05/18/2010US7718796 hydrogenating (3S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)-2,3,4,7-tetrahydro-1H-azepin-3-ammonium salt in presence of cis-selective catalyst; calcitonin gene related peptide (CGRP)
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718686 Gastrointestinal disorders; irritable bowel syndrome
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718667 Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
05/18/2010US7718666 Pyrido [2,1-a] isoquinoline derivatives
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010US7718641 Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2437754C Tablets quickly disintegrated in oral cavity
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2338223C Viologen linked acridine based molecule and process for the preparation thereof
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054253A1 Triazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054114A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
05/14/2010WO2010054113A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
05/14/2010WO2010054078A1 Gamma secretase modulators
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054032A2 Apparatus and method using rotary flow distribution mechanisms
05/14/2010WO2010053438A1 Modulators of amyloid beta.
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010053127A1 MODULATOR OF α1GABAA RECEPTOR OR α5GABAA RECEPTOR
05/14/2010WO2010052726A1 Novel polymorph of moxifloxacin hydrochloride
05/14/2010WO2010052448A2 Fused pyrazine derivatives as kinase inhibitors
05/14/2010WO2010052222A1 (dihydro)naphthyridinone derivatives as histamine h3 receptor antagonists
05/14/2010WO2010052161A2 Herbicidal compositions
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010051781A1 Kinase inhibitors and their use as pharmaceutical agents
05/14/2010WO2010003703A3 Paliperidone ketone
05/14/2010WO2010001408A3 Novel polymorphic forms of gemifloxacin mesylate
05/14/2010WO2009156678A3 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 646